Jasper Therapeutics (JSPR) is presenting updated clinical data from the Phase 1b/2a BEACON study, as well as data from four ...
In other recent news, Jasper Therapeutics has been the subject of several analyst reports following its presentation of data from the BEACON study for briquilimab, a treatment for chronic ...